Name | Number of supported studies | Average coverage | |
---|---|---|---|
goblet cell | 5 studies | 29% ± 8% | |
ciliated cell | 4 studies | 22% ± 4% | |
respiratory goblet cell | 3 studies | 21% ± 6% |
Insufficient scRNA-seq data for expression of PLA2G10 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 47.29 | 328 / 328 | 86% | 21.68 | 153 / 178 |
stomach | 82% | 118.19 | 296 / 359 | 91% | 19.90 | 260 / 286 |
intestine | 77% | 137.67 | 744 / 966 | 91% | 17.86 | 479 / 527 |
lung | 98% | 95.97 | 569 / 578 | 65% | 14.70 | 746 / 1155 |
bladder | 81% | 27.24 | 17 / 21 | 58% | 7.82 | 292 / 504 |
ureter | 0% | 0 | 0 / 0 | 100% | 22.16 | 1 / 1 |
prostate | 78% | 14.09 | 192 / 245 | 13% | 0.38 | 63 / 502 |
esophagus | 26% | 2.23 | 381 / 1445 | 57% | 13.14 | 104 / 183 |
breast | 33% | 3.57 | 152 / 459 | 43% | 2.68 | 479 / 1118 |
uterus | 36% | 3.56 | 61 / 170 | 25% | 2.83 | 116 / 459 |
brain | 53% | 6.49 | 1389 / 2642 | 2% | 0.05 | 12 / 705 |
ovary | 26% | 1.82 | 47 / 180 | 23% | 0.96 | 98 / 430 |
spleen | 35% | 2.56 | 84 / 241 | 0% | 0 | 0 / 0 |
muscle | 30% | 2.37 | 242 / 803 | 0% | 0 | 0 / 0 |
thymus | 17% | 1.19 | 109 / 653 | 11% | 0.79 | 68 / 605 |
skin | 20% | 1.39 | 360 / 1809 | 1% | 0.04 | 6 / 472 |
adipose | 20% | 1.41 | 238 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 14% | 0.94 | 185 / 1335 | 0% | 0 | 0 / 0 |
kidney | 7% | 0.46 | 6 / 89 | 2% | 0.07 | 14 / 901 |
peripheral blood | 6% | 0.42 | 59 / 929 | 0% | 0 | 0 / 0 |
liver | 4% | 0.19 | 8 / 226 | 2% | 0.18 | 10 / 406 |
heart | 5% | 0.33 | 46 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 4% | 0.11 | 2 / 45 |
lymph node | 0% | 0 | 0 / 0 | 3% | 0.16 | 1 / 29 |
adrenal gland | 2% | 0.09 | 4 / 258 | 1% | 0.02 | 2 / 230 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010744 | Biological process | positive regulation of macrophage derived foam cell differentiation |
GO_0036335 | Biological process | intestinal stem cell homeostasis |
GO_0042116 | Biological process | macrophage activation |
GO_0090370 | Biological process | negative regulation of cholesterol efflux |
GO_0051247 | Biological process | positive regulation of protein metabolic process |
GO_0043249 | Biological process | erythrocyte maturation |
GO_2000344 | Biological process | positive regulation of acrosome reaction |
GO_0006658 | Biological process | phosphatidylserine metabolic process |
GO_0051607 | Biological process | defense response to virus |
GO_0031069 | Biological process | hair follicle morphogenesis |
GO_1990830 | Biological process | cellular response to leukemia inhibitory factor |
GO_1900016 | Biological process | negative regulation of cytokine production involved in inflammatory response |
GO_0043030 | Biological process | regulation of macrophage activation |
GO_0090238 | Biological process | positive regulation of arachidonic acid secretion |
GO_0043433 | Biological process | negative regulation of DNA-binding transcription factor activity |
GO_0002532 | Biological process | production of molecular mediator involved in inflammatory response |
GO_0034638 | Biological process | phosphatidylcholine catabolic process |
GO_0034374 | Biological process | low-density lipoprotein particle remodeling |
GO_0009566 | Biological process | fertilization |
GO_0050728 | Biological process | negative regulation of inflammatory response |
GO_0001516 | Biological process | prostaglandin biosynthetic process |
GO_0046470 | Biological process | phosphatidylcholine metabolic process |
GO_0046473 | Biological process | phosphatidic acid metabolic process |
GO_0062234 | Biological process | platelet activating factor catabolic process |
GO_0032308 | Biological process | positive regulation of prostaglandin secretion |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0046337 | Biological process | phosphatidylethanolamine metabolic process |
GO_0010884 | Biological process | positive regulation of lipid storage |
GO_0046471 | Biological process | phosphatidylglycerol metabolic process |
GO_0019369 | Biological process | arachidonic acid metabolic process |
GO_0051977 | Biological process | lysophospholipid transport |
GO_0007411 | Biological process | axon guidance |
GO_0042632 | Biological process | cholesterol homeostasis |
GO_0050482 | Biological process | arachidonic acid secretion |
GO_0005615 | Cellular component | extracellular space |
GO_0001669 | Cellular component | acrosomal vesicle |
GO_0005576 | Cellular component | extracellular region |
GO_0005764 | Cellular component | lysosome |
GO_0004620 | Molecular function | phospholipase activity |
GO_0047498 | Molecular function | calcium-dependent phospholipase A2 activity |
GO_0005543 | Molecular function | phospholipid binding |
GO_0004623 | Molecular function | phospholipase A2 activity |
GO_0003847 | Molecular function | 1-alkyl-2-acetylglycerophosphocholine esterase activity |
GO_0005509 | Molecular function | calcium ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | PLA2G10 |
Protein name | Phospholipase A2 (EC 3.1.1.4) Alternative protein PLA2G10 Group 10 secretory phospholipase A2 (EC 3.1.1.4) (Group X secretory phospholipase A2) (GX sPLA2) (sPLA2-X) (Phosphatidylcholine 2-acylhydrolase 10) |
Synonyms | hCG_1746186 |
Description | FUNCTION: Secretory calcium-dependent phospholipase A2 that primarily targets extracellular phospholipids . Hydrolyzes the ester bond of the fatty acyl group attached at sn-2 position of phospholipids with preference for phosphatidylcholines and phosphatidylglycerols over phosphatidylethanolamines. Preferentially releases sn-2 omega-6 and omega-3 polyunsaturated fatty acyl (PUFA) chains over saturated fatty acyls . Contributes to phospholipid remodeling of very low-density lipoprotein (VLDL), low-density lipoprotein (LDL) and high-density lipoprotein (HDL) particles . Hydrolyzes LDL phospholipids releasing unsaturated fatty acids that regulate macrophage differentiation toward foam cells . Efficiently hydrolyzes and inactivates platelet activating factor (PAF), a potent lipid mediator present in oxidized LDL . May act in an autocrine and paracrine manner. Secreted by lung epithelium, targets membrane phospholipids of infiltrating eosinophils, releasing arachidonate and boosting eicosanoid and cysteinyl leukotriene synthesis involved in airway inflammatory response (By similarity). Secreted by gut epithelium, hydrolyzes dietary and biliary phosphatidylcholines in the gastrointestinal lumen (By similarity). Plays a stem cell regulator role in colon epithelium. Within intracellular compartment, mediates Paneth-like cell differentiation and its stem cell supporting functions by inhibiting the Wnt signaling pathway in intestinal stem cell (ISC). Secreted in the intestinal lumen upon inflammation, acts in an autocrine way and promotes prostaglandin E2 synthesis that stimulates Wnt signaling pathway in ISCs and tissue regeneration (By similarity). May participate in hair follicle morphogenesis by regulating phosphatidylethanolamines metabolism at the outermost epithelial layer and facilitating melanin synthesis (By similarity). By releasing lysophosphatidylcholines (LPCs) at sperm acrosome, controls sperm cell capacitation, acrosome reaction and overall fertility (By similarity). May promote neurite outgrowth in neuron fibers involved in nociception (By similarity). Contributes to lipid remodeling of cellular membranes and generation of lipid mediators involved in pathogen clearance. Cleaves sn-2 fatty acyl chains of phosphatidylglycerols and phosphatidylethanolamines, which are major components of membrane phospholipids in bacteria . Displays bactericidal activity against Gram-positive bacteria by directly hydrolyzing phospholipids of the bacterial membrane . In pulmonary epithelium, may contribute to host defense response against adenoviral infection. Prevents adenovirus entry into host cells by hydrolyzing host cell plasma membrane, releasing C16:0 LPCs that inhibit virus-mediated membrane fusion and viral infection. Likely prevents adenoviral entry into the endosomes of host cells . May play a role in maturation and activation of innate immune cells including macrophages, group 2 innate lymphoid cells and mast cells (By similarity). . |
Accessions | ENST00000567462.1 ENST00000621727.2 L8E7V2 H3BRW4 ENST00000634009.1 O15496 ENST00000438167.8 |